Lates News

According to the AI quick news, Dongwu Securities issued a research report on November 2 giving a "buy" rating to Daisenlin (603233.SH). The rating reasons mainly include: 1) Events: The company achieved revenue of 20.068 billion yuan in the first three quarters of 2025 (+1.71% year-on-year), net profit attributable to the parent company was 1.081 billion yuan (+25.97%), and non-recurring net profit attributable to the parent company was 1.073 billion yuan (+25.93%). Revenue in 2025Q3 reached 6.546 billion yuan (+2.51%), net profit attributable to the parent company was 280 million yuan (+41.04%), exceeding our expectations; 2) The growth rate of traditional Chinese and Western medicine is fast; 3) Significant cost reduction and efficiency improvement; 4) The speed of franchise expansion leads the industry. (Daily Economic News)